Approvals/NMPA/Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）

Approved

化学药品

Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）

上海迪赛诺医药集团股份有限公司🇨🇳 National Medical Products Administration

Approval Id: 8TCguMgwivv
Approval Number: 国药准字H20233988
Generic Name: 依非米替片(Ⅰ)
Generic Name En: Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets（Ⅰ）
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含依非韦伦0.4g，拉米夫定0.3g，富马酸替诺福韦二吡呋酯0.3g
Reg Date: 2023-08-01
Company Name: 上海迪赛诺医药集团股份有限公司
Company Address: 中国（上海）自由贸易试验区张衡路1479号1幢
Production Company Name: 上海迪赛诺医药集团股份有限公司
Production Company Address: 中国（上海）自由贸易试验区张衡路1479号
Company Detail Path: /organization/shang-hai-di-sai-nuo-yi-yao-ji-tuan-gu-fen-you-xian-gong-si
Production Company Detail Path: /organization/shang-hai-di-sai-nuo-yi-yao-ji-tuan-gu-fen-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 1, 2023

Approval ID

8TCguMgwivv

Type

化学药品